Respiratory Drug Delivery is a conference that covers topics such as:
- Connected inhaler case studies and how digital integration can enable better patient experience and adherence
- The latest approaches to enable sustainability for respiratory devices with a case study on an inhaler platform with a near-zero carbon footprint propellant
- The latest strategies to enhance patient usability for increased correct device use and better health outcomes
- Key drug formulation and biopharmaceutical considerations for efficient delivery to the respiratory system with key insights from AstraZeneca on biopharmaceutic modelling
- The MHRA, BSI and GSK on the latest regulatory requirements for respiratory devices, including Article 117, and ensuring legacy devices are in line with updated regulations
Respiratory Drug Delivery brings together senior attendees with responsibilities in:
- Device Engineering
- Device Development
- Drug Delivery Devices
- Combination Product Development
- Digital Health
- Primary Packaging Development
- Drug Product Development
- Novel Drug Product Formulation
- Medical Affairs
- Regulatory Affairs
